πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

227 results for β€œShi” Clear

  1. HEC73077 tablets

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Diabetic Nephropathy

    phase 1 small molecule completed

    1 trial

  2. HEC74647

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chronic Hepatitis C

    phase 1 small molecule completed

    1 trial

  3. HEC74647PA capsule

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chronic Hepatitis C

    phase 1 small molecule completed

    2 trials

  4. HEC83518

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Insomnia

    phase 1 small molecule completed

    1 trial

  5. HEC83518 tablets

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Insomnia

    phase 1 small molecule completed

    1 trial

  6. HEC89736

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Relapsed or Refractory B-cell Hematologic Malignancies

    phase 1 small molecule terminated

    1 trial

  7. HEC93077

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Gout

    phase 1 small molecule completed

    1 trial

  8. HEC96719

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Nonalcoholic Steatohepatitis (NASH)

    phase 1 small molecule completed

    1 trial

  9. HEC96719

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Non-alcoholic Fatty Liver Disease

    phase 1 small molecule completed

    1 trial

  10. HEC96719 tablets

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Nonalcoholic Steatohepatitis (NASH)

    phase 1 small molecule completed

    1 trial

  11. Humanized TNFΞ± monoclonal antibody

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Rheumatoid Arthritis

    phase 1 small molecule completed

    1 trial

  12. Insulin degludec injection, RD15003

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Type 2 Diabetes

    phase 1 mab completed

    1 trial

  13. Kangdaprevir Sodium Tablet

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chronic Hepatitis c

    phase 1 small molecule completed

    1 trial

  14. Larotinib

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  15. Larotinib

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Esophageal Cancer

    phase 1 small molecule active

    1 trial

  16. Liraglutide injection,RD12014

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Type 2 Diabetes

    phase 1 small molecule completed

    1 trial

  17. Litapiprant Tablet

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Asthma

    phase 1 small molecule completed

    1 trial

  18. Midazolam Syrup

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy Subjects

    phase 1 small molecule completed

    1 trial

  19. PEGylated recombinant candida urate oxidase

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Gout

    phase 1 small molecule active

    1 trial

  20. Pegylated Recombinant Candida Utilis Uricase for Injection

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Gout

    phase 1 small molecule active

    1 trial

  21. Placebo

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy

    phase 1 small molecule completed

    1 trial

  22. RJK-RT2831 dose-escalation phase Ia

    Nanjing Zenshine Pharmaceuticals

    Hematologic Malignancies

    phase 1 small molecule active

    1 trial

  23. Recombinant erythropoietin stimulating protein

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chronic Renal Failure

    phase 1 small molecule active

    1 trial

  24. Recombinant human thrombopoietin

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Liver Cirrhosis

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources